Judge Asked To Skillax To Attend ‘Stairway’

Escrito por el 18 — 05

«Consider heart disease, the No. 1 killer of women, killing more women than all cancers combined. If we can do more to prevent, treat and cure cardiovascular disease, more women will live longer, more families will stay together, more workers will stay productive, and we’ll save money on treating a condition that costs the U.S. nearly a billion dollars a day.

«Moreover, diversifying research and clinical trials will improve health outcomes for everyone. Better understanding of sex differences will not only fill in critical gaps on women’s health but can improve men’s health as well.

«To give an example, looking at disease through the sex and gender lens has driven new insights regarding atrial fibrillation (AFib), a dangerous condition marked by an irregular heartbeat that can lead to stroke, blood clots, heart failure and other heart complications. For many years, research failed to find an association between physical activity and AFib. Once researchers stratified their research findings by sex, they were able to show that physical activity was associated with an increased risk of AFib in men while significantly reducing the likelihood of AFib in women.

Many other areas of health are affected by sex and gender, from susceptibility to depression to response to medication to addiction to nicotine and other drugs. When a clinical trial includes sex and gender analysis, it not only demonstrates how a treatment’s efficacy varies for men and women, it helps illuminate possibilities for even more promising medications and cures.

«Last month, the U.S. Senate HELP Committee passed a series of biomedical innovation bills, which can be bundled into a companion to the House-passed 21st Century Cures Act. We applaud this bipartisan commitment to fighting disease and saving lives. One of the Senate bills is the Advancing NIH Strategic Planning and Representation in Medical Research Act. It’s a fancy name for a simple idea: securing equity in biomedical research. Especially at a time of constrained resources and competing priorities, Americans deserve the best possible return on our nation’s biomedical research investments. We urge the Congress to pass this legislation, for our health and for our future.»


Opiniones
  1. Commenter 209   /   21 — 05, (5.19)

    orta et, molestie vitae, imperdiet eget, purus. Mauris iaculis. In cursus, neque eu sollicitudin ullamcorper, odio mauris tempus odio, id tincidunt metus leo vel ipsum. Quisque suscipit. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nullam sed libero. Nunc sollicitudin diam ac dui. Nunc faucibus auctor tortor. Quisque ipsum sem, hendrerit accumsan, congue ut, porttitor ut, turpis. Sed sollicitudin, leo et condimentum tempus, massa augue dictum est, iaculis posuere nulla felis quis tortor. Pellentesque ac nisl vitae

  2. Commenter 210   /   21 — 05, (5.19)

    nulla. Sed a neque. Fusce tempus tortor ut diam. Quisque sagittis lacus eget velit. Quisque augue magna, commodo in, molestie nec, convallis at, tortor. Etiam blandit ultrices tortor. Aliquam nisi risus, lobortis vitae, elementum pulvinar, viverra vel, dolor. Donec metus urna, faucibus aliquet, egestas in, adipiscing sit amet, risus. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Proin nisi. Nunc hendrerit nisi lobortis purus.

    Vivamus turpis ante, ultrices scelerisque, elementum id, tempor at, quam. Cras eu mauris eu nulla congue convallis. Fusce ornare, nibh sit amet porta rhoncus, nibh metus tincidunt magna, quis gravida dui neque pharetra risus. Etiam a felis. Fusce sed dolor. Mauris lect

  3. Commenter 211   /   21 — 05, (5.19)

    e ante elit, vestibulum eget, laoreet dictum, pulvinar vitae, velit. Mauris vel augue quis enim ornare imperdiet.

    Phasellus sed tellus eget lacus molestie laoreet. Phasellus commodo euismod mauris. Sed facilisis nulla a est. Proin sit amet lectus. Morbi suscipit libero a nisl. Sed quam ipsum, ullamcorper non, congue vitae, ornare non, nisl. Nunc ultrices. Aliquam imperdiet velit sit amet nulla. Sed a neque. Fusce tempus tortor ut diam. Quisque sagittis lacus eget velit. Quisque augue magna, commodo in, molestie nec, convallis at, tortor. Etiam blandit ultrices tortor. Aliquam nisi risus, lobortis vitae, elementum pulvinar, viverra vel, dolor. Donec metus urna, faucibus aliquet, egestas in, adipiscing sit amet, risus. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Proin nisi. Nunc hendrerit nisi lobortis purus.

    Vivamus turpis ante,

  4. Commenter 212   /   21 — 05, (5.19)

    ctetur adipiscing elit. Praesent pulvinar pellentesque lacus. Suspendisse urna orci, rutrum a, placerat a, suscipit a, est. Aliquam ac odio. Fusce arcu lorem, sodales et, condimentum ultrices, fringilla ut, tellus. Quisque velit justo, molestie ac, imperdiet et, vulputate semper, dolor. Phasellus laoreet, sapien in molestie gr

  5. Commenter 213   /   21 — 05, (5.19)

    t nisi. Nullam in magna quis libero posuere vestibulum. Donec mi leo, elementum ut, tincidunt at, condimentum eu, est. Donec sed nisl ac justo consectetur viverra. Nulla volutpat est vitae nisl. Nullam aliquam ipsum a arcu facilisis adipiscing. Pellentesque cursus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Nulla gravida viverra urna.

    Aenean condimentum, arcu sit amet volutpat ullamcorper, erat sapien tempor dolor, ac consectetur diam ante at nibh. Pro

Los comentarios están cerrados.


Canción actual

Título

Artista

Background